1.
Chinese Pharmacological Bulletin
;
(12): 414-415, 2010.
Artigo
em Chinês
| WPRIM
| ID: wpr-403326
RESUMO
Niacin, a broad-spectrum lipid-regulating agent, can significantly lower plasma triglyceride and raise the high density lipoprotein-cholesterol.Extended-release niacin added to statins monotherapy could further modify the lipid profile and reduce residual cardiovascular risk.This combination therapy provides a safe, effective and economical treatment for clinicians and may be superior to other drugs combined with statins.